Softgel Source, LLC has introduced a new program for rapid turnaround of low volume, custom ingestible softgels, positioning itself to support U.S. biotech and pharmaceutical businesses in accelerating product development. The initiative, based in Portland, Oregon, provides production priority and eliminates minimum order quantities, enabling companies to swiftly test and refine softgel products. This move comes as U.S. manufacturing, particularly in biotech and pharmaceuticals, is projected to grow 6–8% annually through 2030, according to a study from Deloitte and The Manufacturing Institute.
Kevin McDowell, Founder and CEO of Softgel Source, emphasized the strategic importance of domestic manufacturing, stating that U.S. companies are at a crossroads in bringing production back home. By operating from its headquarters in Portland, the company aims to help businesses rapidly develop and test new formulations, enhancing their competitive edge. The program addresses challenges faced by companies reliant on offshore manufacturing, such as disrupted supply chains, long lead times, and shifting tariffs, by offering a responsive, U.S.-based alternative.
The expansion of fast turnaround operations aligns with a nationwide surge in manufacturing, which is expected to create millions of new jobs this decade. Softgel Source's location in the Pacific Northwest allows it to assist companies in diversifying and expanding their operations by providing high-quality, compliant softgels at accelerated rates. This is particularly valuable for industries like biotech and nutritional supplements, where efficiency and consistency are critical. The company also serves as a backup production source when international suppliers encounter issues, further stabilizing supply chains.
Regulatory changes in the U.S. and internationally pose additional challenges for softgel suppliers, often requiring rapid reformulation and retesting of products. Softgel Source's low minimum order quantity and fast turnaround capabilities make it an ideal partner for companies navigating these time-sensitive requirements. By enabling quick adaptation to new regulations, the program helps businesses maintain compliance and minimize disruptions, supporting growth in a dynamic market environment.
As a boutique manufacturer focused on custom ingestible softgels for vitamins, medications, supplements, and pet products, Softgel Source emphasizes high-touch service for U.S.-based clients. The new prototyping program underscores the company's commitment to responsive, rapid turnaround in prototype production and low-to-moderate volume manufacturing. For more information, visit https://softgelsource.com.
